Product Program year 2020 Source: CMS Open Payments

MD cobas Instruments and Reagents

Device Molecular Diagnostics

Open in the dashboard

General payments

$246,551

1,510 payments

Research payments

$120,812

4 payments

Through program year 2020, $246,551 in general payments and $120,812 in research payments were reported against MD cobas Instruments and Reagents (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $92,653 152
2019 General $153,897 1,358
2019 Research $120,812 4

Breakdown

Who paid General payments · program years 2019–2020
  1. Roche Diagnostics Corporation $246,551 1,510 payments
Top recipients General payments · program year 2020
  1. University Of Washington Med Ctr Teaching hospital · WA $44,271 48% · 24 payments
  2. Megan App Obstetrics & Gynecology · Portage, IN $5,563 6% · 2 payments
  3. Susanne Lewis Infectious Disease · Miami, FL $4,500 5% · 1 payment
  4. Daniel Brennan Nephrology · Baltimore, MD $2,900 3% · 1 payment
  5. Jeffrey Klausner Infectious Disease · Los Angeles, CA $2,900 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Infectious Disease Internal Medicine $23,800 53% · 8 practitioners
  2. Obstetrics & Gynecology $7,532 17% · 78 practitioners
  3. Nephrology Internal Medicine $2,900 6% · 1 practitioner
  4. Clinical Pathology/Laboratory Medicine Pathology $2,900 6% · 1 practitioner
  5. Emergency Medicine $2,425 5% · 2 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Washington $44,271 48% · 1 recipient
  2. California $9,090 10% · 20 recipients
  3. Illinois $8,927 10% · 4 recipients
  4. Louisiana $4,800 5% · 2 recipients
  5. Florida $4,562 5% · 5 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,510 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record